Trial Profile
Phase II Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bixalomer (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 03 May 2016 New trial record